Skip to main content
Premium Trial:

Request an Annual Quote

Laboratoires Fournier Licenses BioBase's Transcription Database

NEW YORK (GenomeWeb News) — French company Laboratoires Fournier will license BioBase’s TRANSFAC eukaryotic gene-regulation database, BioBase said today.
 
BioBase said the Dijon-based company will use the database to develop therapeutics for metabolic and cardiovascular diseases.
 
BioBase, headquartered in Wolfenbuttell, Germany, said the TRANSFAC database holds information on 8,700 transcription factors and is used to identify and analyze binding sites.
 
The company said the database, which it updates every three months, also visualizes, interprets, and predicts gene-regulatory networks.
 
Financial terms of the agreement were not released.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.